Alpha-GPC is often touted as a supplement that "increases strength in the bench press" and "strengthens the brain-to-muscle connection." There is some real research behind these promises, but few and far between. The editors analyzed key papers, their design and limitations to answer a simple question: how compelling is the evidence base for athletes.
Why is Alpha-GPC being researched in sports at all
The logic of using Alpha-GPC in sports is based on the role of acetylcholine in neuromuscular transmission. Each skeletal muscle contraction begins with the release of acetylcholine at the synapse between the motor neuron and the muscle fiber. Assuming that choline availability can be a limiting factor during intense exercise, then supplemental choline is theoretically capable of supporting strength and speed.
Interest in this hypothesis was strengthened by the observations of the 1980s and 1990s, in which a decrease in plasma choline concentration was recorded after long endurance competitions, such as a marathon. However, these data mostly related to long loads, and not to short strength sets.
Alpha-GPC has become the number one candidate for choline sources due to its high bioavailability and ability to effectively increase blood choline levels. In addition, in pharmacological works, it was associated with an increase in the secretion of growth hormone, which made the substance even more attractive for marketing.
So, the researchers tested several hypotheses: whether Alpha-GPC increases maximal strength and power, whether it affects the hormonal response to training, whether it improves endurance and cognitive performance during exercise. Let's consider them sequentially.
Strength and Power: Key Studies
The most cited work is a study by Ziegenfuss, Landis, and Hofheins (2008), published as an abstract in the Journal of the International Society of Sports Nutrition. Young trained men were given 600 mg of Alpha-GPC approximately 90 minutes before strength training. The authors reported higher peak force in the bench press and a greater rise in growth hormone after exercise compared to placebo.
Importantly, these were conference abstracts with a small number of participants, rather than a full peer-reviewed article detailing methods. This format does not allow to fully assess the risk of systematic errors, so these results should be taken as a signal for further research.
In a randomized, double-blind study by Bellar, LeBlanc, and Campbell (2015), male college students took 600 mg of Alpha-GPC daily or a placebo for six days. After the course, the Alpha-GPC group showed greater strength gains in isometric mid-thigh pull, while upper body strength did not differ significantly.
Marcus et al (2017) compared two doses—250 mg and 500 mg daily for one week—with placebo. The researchers reported improvements in some measures of lower extremity strength, but without a clear "higher dose-higher effect" relationship, and a number of other tests were unchanged. This mixed result is typical of small samples.
| Research | Protocol | Main result | Limitations |
|---|---|---|---|
| Ziegenfuss et al., 2008 | 600 mg once before training | Higher peak force in bench press, greater increase in growth hormone | Conference abstracts, small sample |
| Bellar et al., 2015 | 600 mg/day, 6 days | Greater isometric strength of the lower limbs | Short course, men only |
| Marcus et al., 2017 | 250 or 500 mg/day, 7 days | Partial improvement in leg strength | Mixed results, no dose dependence |
| Kawamura et al., 2012 | 1000 mg once | Growth hormone increase, fat oxidation | Acute effect, without evaluation of results |
Growth hormone and fat oxidation
Japanese researchers Kawamura et al. (2012) in the journal Nutrition reported that a single dose of Alpha-GPC in young adults increased the concentration of growth hormone in the blood and shifted the metabolism towards fat oxidation. This result is often advertised as proof of an "anabolic" or "fat-burning" effect.
However, a short-term increase in growth hormone in the blood is not equal to an increase in muscle mass. Physiological peaks of growth hormone occur both during sleep and after intense training, and studies with direct assessment of muscle protein synthesis have shown that such acute fluctuations have little effect on hypertrophy.
None of the known studies have demonstrated that long-term use of Alpha-GPC changes body composition—increases lean mass or decreases fat mass—compared to a placebo given the same training and nutrition.
Therefore, hormonal data should be considered as a mechanistic touch that explains possible effects, and not as an independent reason to take the supplement. For gaining muscle mass, protein, the total caloric content of the diet and the progression of exercise are much more important.
Endurance, attention and reaction speed
There are practically no direct qualitative studies of Alpha-GPC on endurance. Most of the data on choline and sustained exercise have been obtained with other forms, particularly choline bitartrate. In a controlled study by Warber et al (2000), choline supplementation did not improve performance in an endurance test, although plasma choline levels increased.
For cognitive performance during exercise, Alpha-GPC is often combined with caffeine. In such designs, it is difficult to isolate the contribution of each ingredient: caffeine has a strong evidence base for attention and reaction time, so it often explains the effect of the mixture.
Marcus et al. (2017) did not find clear psychomotor benefits. A later randomized crossover study in 20 trained men, published in December 2024, found improvement on the Stroop test but not the N-Back or Flanker tests, physical performance or growth hormone. Clinical findings from older adults with dementia cannot simply be transferred to athletes.
Thus, for sports where endurance or tactical thinking are important, the arguments in favor of Alpha-GPC today are even less than for strength disciplines.
Strengths and weaknesses of the evidence base
Strengths include consistency: several independent groups have reported some improvement in strength, particularly in the lower extremities, and these effects have a plausible physiological explanation. In addition, no serious adverse reactions were recorded in short studies.
There are more weaknesses. The samples are small, the participants are mostly young men, the supplementation period is from one day to a week. Different strength tests are used, making comparisons difficult. Part of the data is published only as conference abstracts, and independent reproductions are lacking.
- The studies discussed here do not establish a strong pooled athletic-performance effect.
- Long-term training and body-composition outcomes remain insufficiently established.
- Little data on women and high-level athletes.
- Part of the work was financed by ingredient manufacturers.
Separately, safety issues with long-term use should be considered: a cohort study by Lee et al. (2021) found an association between the use of Alpha-GPC and an increased risk of stroke. This observational study does not prove a cause-and-effect relationship, but it does make the idea of "taking it all the time" more cautious.
In conclusion, Alpha-GPC is in the supplement category with “promising but insufficient” data. It does not belong to a group with a strong evidence base like creatine, caffeine or beta-alanine.
Editorial conclusions
The evidence base for Alpha-GPC in athletes consists of several small, short-term studies that generally indicate a possible modest increase in strength, primarily in the lower extremities.
Some small studies reported short-lived growth-hormone effects, but findings are not consistent and have not been proven to affect muscle mass. There is almost no data on endurance and cognitive performance in healthy athletes.
If an athlete decides to try Alpha-GPC, it should be taken as an experimental second-line supplement, not as the foundation of a program. Basic factors - training, sleep, nutrition - will give an incomparably greater result.
For a deeper understanding of the topic, we recommend our articles on the side effects of Alpha-GPC, on caffeine as an ergogenic agent, and on the evidence base for creatine.
References
- Ziegenfuss T, Landis J, Hofheins J. Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. J Int Soc Sports Nutr. 2008;5(Suppl 1):P15.
- Bellar D, LeBlanc NR, Campbell B. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. J Int Soc Sports Nutr. 2015;12:42.
- Marcus L, Soileau J, Judge LW, Bellar D. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. J Int Soc Sports Nutr. 2017;14:39.
- Kawamura T, Okubo T, Sato K, et al. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adults. Nutrition. 2012;28(11–12):1122–1126.
- Warber JP, Patton JF, Tharion WJ, et al. The effects of choline supplementation on physical performance. Int J Sport Nutr Exerc Metab. 2000;10(2):170–181.
- Lee G, Choi S, Chang J, et al. Association of L-α glycerylphosphorylcholine with subsequent stroke risk after 10 years. JAMA Netw Open. 2021;4(11):e2136008.
